新型冠状病毒

Moderna’s Covid jab shows 94.5% efficacy in clinical trials

Second set of positive results in 8 days further boosts hope vaccines will be effective

US biotech Moderna said its Covid-19 vaccine had shown 94.5 per cent efficacy in clinical trials, in the second positive set of results for a potential coronavirus shot in the past eight days.

Last week, US pharmaceutical company Pfizer and Germany’s BioNTech also said their vaccine, which uses the same messenger RNA technology, was found to be more than 90 per cent effective.

The Moderna finding, hot on the heels of that breakthrough, will further boost optimism that the world can turn the corner in the management of the pandemic.

您已阅读19%(535字),剩余81%(2277字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×